logo

Omeros Corp. (OMER)



Trade OMER now with
  Date
  Headline
8/31/2020 8:11:55 AM Omeros' Investigational New Drug Application For OMS906 Cleared By FDA
8/12/2020 6:35:01 AM Omeros Reports Pricing Of Public Offerings Of 6.9 Mln Common Shares And $210 Mln 5.25% Convertible Senior Notes Due 2026
8/10/2020 4:05:46 PM Omeros Q2 Loss/share $0.61 Vs. Loss $0.29 Year Ago
8/10/2020 7:52:22 AM Omeros Reports Recovery Of Patients In Study Evaluating Narsoplimab For COVID-19 Patients With ARDS
6/11/2020 8:52:41 AM Omeros To Share Narsoplimab Pivotal Trial Data At Annual European Hematology Association Congress
5/14/2020 9:05:54 AM Omeros Announces Presentation Of Narsoplimab Pivotal Trial Data
3/2/2020 4:15:19 PM Omeros Q4 Loss/share $0.58 Vs. Loss $0.48 Year Ago
12/18/2019 8:35:52 AM MyTomorrows And Omeros Collaborate To Provide Expanded Access Program For Narsoplimab
12/5/2019 9:33:46 AM Omeros Prices Public Offering Of $50.0 Mln In Shares At $13.10 Per Share
12/4/2019 7:04:42 AM Omeros Reports Positive Data In Pivotal Trial Of HSCT-TMA Patients Treated With Narsoplimab
11/4/2019 7:53:52 AM Omeros Announces Publication Of Study Results On Impact Of OMIDRIA On Opioid Use And Pain
10/28/2019 8:51:02 AM Omeros Initiates BLA Submission For Narsoplimab For Treatment Of HSCT-TMA
7/31/2019 8:36:40 AM Omeros, Lonza Announce Long-term Manufacturing Agreement For Narsoplimab
7/31/2019 8:34:21 AM Omeros And Lonza Enter Long-Term Manufacturing Agreement For Commercial Supply Of Narsoplimab
7/15/2019 6:17:18 AM Wedbush Reiterates Omeros Corp. (OMER) At Neutral With $18 Price Target